Gao J, Caplan A I
Skeletal Research Center, Department of Biology, Case Western Reserve University, Cleveland, Ohio, USA.
Chir Organi Mov. 2003 Jul-Sep;88(3):305-16.
Bone marrow contains multipotent mesenchymal stem cells (MSCs) that can differentiate into different mesenchymal lineages whose end-stage cells fabricate bone, cartilage, tendon, fat, and other connective tissues. Our laboratory has been focusing on the purification, culture expansion, the in vivo and the in vitro characterization of MSCs and their descendants. Given the large number of MSCs that can be generated, we have explored their use in different pre-clinical models utilizing the therapeutic potentials of MSCs for musculoskeletal disorders. Using newly evolved tissue engineering principals, we have focus on the treatment of full thickness cartilage damage and, separately, bone non-union. The experimental results suggest the MSCs may provide a powerful therapeutic tool for the treatment of musculoskeletal disorders. Future efforts should be made to establish reliable and standardized full-scale clinical approaches using MSCs for orthopaedic surgery.
骨髓中含有多能间充质干细胞(MSCs),这些细胞可分化为不同的间充质谱系,其终末细胞能生成骨骼、软骨、肌腱、脂肪及其他结缔组织。我们实验室一直专注于MSCs及其后代的纯化、培养扩增、体内和体外特性研究。鉴于可生成大量的MSCs,我们利用MSCs对肌肉骨骼疾病的治疗潜力,探索了其在不同临床前模型中的应用。运用新发展的组织工程原理,我们专注于全层软骨损伤的治疗,另外还关注骨不连的治疗。实验结果表明,MSCs可能为治疗肌肉骨骼疾病提供一种强大的治疗工具。未来应努力建立可靠且标准化的全面临床方法,将MSCs用于骨科手术。